A Target Without a Peptide Lead
Begin with a protein target and a biological question. We assess available structural information and identify a suitable design region before generating first-generation candidates.
Target-focused macrocycle discovery
Start with your target. Build diverse macrocyclic peptide candidates for synthesis and experimental testing.
CD ComputaBio combines AI-guided molecular design, structural analysis and chemistry review to develop new peptide starting points for your discovery program.
A new starting point for your target
De novo cyclic peptide design creates new peptide sequences and constrained backbones around a defined molecular objective. A known peptide lead is not required. The aim is to propose chemically defined candidates whose predicted structures and target interactions justify a first experimental campaign.
As part of our peptide drug design and development services, this service supports target-binding macrocycles for therapeutic discovery, targeted delivery and research. The design brief sets the required binding site, functional objective, selectivity profile and downstream use before candidate generation begins.
Begin with a protein target and a biological question. We assess available structural information and identify a suitable design region before generating first-generation candidates.
Use a known epitope, interaction hotspot, partner interface or competing ligand to guide where the macrocycle should bind and which interactions it should reproduce.
Discover a targeting peptide for a conjugate, imaging probe or radioligand program. Potential attachment positions and the intended assay format enter the initial design constraints.
Already have a peptide sequence and activity data? Share the existing series so we can scope focused redesign and optimization within the same project discussion.
First, understand the binding opportunity
A useful design campaign starts with a biologically relevant target model. We review the protein construct, domain boundaries, oligomeric state and structural coverage, then examine the accessibility and shape of the proposed interface.
Experimental structures, predicted models and known complexes provide different levels of support. Flexible loops, unresolved regions, glycans and membrane proximity can change whether a modeled surface is accessible in the assay or native setting.
When only a sequence is available, structure prediction and confidence assessment establish whether the design region is sufficiently supported. Alternative constructs or additional structural information may be recommended before a large campaign.
Share a target and preferred binding region →Co-design the complete molecule
Ring topology determines which conformations a peptide can access. Sequence design and closure chemistry are evaluated together to build candidates suited to the target surface and subsequent synthesis.
Generate or sample constrained backbones around the selected site, exploring ring size, backbone geometry and hotspot placement. Diverse starting geometries help test more than one binding hypothesis.
Output: representative backbone families and proposed binding orientations.
Select residues that complement the local surface through shape, hydrogen bonding, electrostatics and hydrophobic contacts. Evaluate intramolecular packing alongside the peptide–protein interface.
Output: candidate sequences with annotated contact hypotheses.
Consider head-to-tail or side-chain closure and suitable linkage chemistries. Review closure geometry, ring strain, residue availability and protecting-group requirements with the planned synthetic route.
Output: a defined connectivity map and closure strategy for each candidate.
Evaluate D-amino acids, noncanonical side chains and selected backbone modifications where structural methods and synthesis support them. Expansion can be staged after an initial conventional design series.
Output: chemically specified variants with clear stereochemistry and modification sites.

Diversity with a purpose
A first synthesis set should capture meaningful differences in backbone shape, sequence and contact pattern. Closely related variants can probe a specific interaction; structurally distinct candidates explore alternative solutions.
For programs that need a broader experimental search, our peptide library design services can help define a complementary library strategy. A computational candidate set and a display library require different construction and testing plans.
From generated structures to a synthesis decision
Candidate ranking combines complementary evidence. Structure prediction, interface analysis and selected physics-based calculations address different questions; together they help identify a balanced first batch and explain why each molecule is included.
| Assessment | What We Examine | How It Supports Selection |
|---|---|---|
| Binding geometry | Surface complementarity, hotspot contacts, clashes and exposed hydrophobic patches. | Retain plausible interaction hypotheses for experimental testing. |
| Conformational support | Agreement between design and independent predictions, structural confidence and alternative conformations. | Identify candidates more likely to support the intended binding geometry. |
| Dynamic behavior | Conformational sampling and complex simulations for selected candidates. | Investigate flexibility and contact persistence under the chosen simulation conditions. |
| Selectivity hypotheses | Differences at the intended site across selected homologs or counter-targets. | Prioritize discriminating interactions and plan the relevant counterscreens. |
| Developability signals | Charge, hydrophobicity, potential aggregation and accessible proteolytic liabilities. | Balance predicted binding with practical handling and follow-up requirements. |
| Chemistry and diversity | Building blocks, connectivity, ring closure, purification risk and structural clustering. | Choose a synthetically practical set that spans distinct design hypotheses. |
Computational scores support relative prioritization. Binding affinity, selectivity and biological activity are established through the corresponding experiments.
Make the next experiment count
Computational delivery can stand alone or continue into an agreed experimental scope. Chemistry review is incorporated before committing to synthesis, with test conditions, controls and decision criteria defined around the intended use.
Prepare selected macrocycles, introduce agreed modifications and purify material for testing. HPLC and LC-MS support purity and mass assessment; connectivity, stereochemistry or conformation questions may require additional methods.
Decision: which candidates meet the agreed identity, purity and handling requirements?
Use suitable biophysical assays such as SPR or BLI to assess binding. Competition, homolog counterscreens and cell-based studies can then address site engagement, selectivity and the intended biological effect.
Decision: which molecules warrant confirmation, functional characterization or optimization?
Map positive and negative results back to the structural hypotheses. Examine whether sequence changes, ring topology or assay behavior explain the observations, then propose a focused analog series.
Decision: refine the current family, investigate a different binding pose or explore a new scaffold?
After binding confirmation, peptide developability assessment can guide stability and property studies. Conjugate projects additionally examine whether attachment preserves binding and supports the required uptake or retention profile.
A reviewable molecular design package
Deliverables are matched to the selected computational and experimental scope. Candidate numbers, synthesis quantities, analytical specifications, assay formats and iteration rounds are defined in the project proposal.
Prepared target models, structural assumptions, selected design regions and the rationale connecting the proposed site to the biological objective.
Sequences, residue stereochemistry, noncanonical building blocks, modification positions and explicit cyclization connectivity for each nominated molecule.
Candidate and target-complex coordinates, representative poses and interface annotations, with file formats selected to preserve the relevant chemistry.
Assessment criteria, structural family assignments, synthesis considerations and a transparent explanation of the proposed first experimental set.
Agreed analytical and assay results, sample identifiers, controls, conditions and interpretation linked to the corresponding design version.
A concise technical report with method and parameter records, conclusions supported by the available evidence and recommended analogs or validation steps.
Design around the downstream use
The required biology shapes both the candidate design and the evidence needed to advance it.
Design candidates for accessible receptor domains, enzymes or soluble proteins. Binding confirmation can be followed by ligand competition and functional assays suited to the mechanism.
Explore macrocycles at selected interaction hotspots. Competition and pathway assays test whether binding translates into modulation; intracellular applications also require evidence of cellular access and engagement.
Seek ligands that tolerate attachment at suitable positions. Follow-up evaluates conjugated binding, target-dependent uptake or retention, and properties relevant to the intended payload.
Develop molecular starting points for target interrogation and assay development. Labels or handles are introduced at positions chosen to preserve the binding hypothesis.
Pursuing oral exposure? Explore our oral cyclic peptide design program for absorption-focused design, permeability assessment and oral development planning.
Scientific foundation
Published work on RFpeptides describes a target-directed pipeline connecting backbone generation, sequence design and cyclic peptide–protein complex prediction, followed by experimental testing.1 AfCycDesign research also demonstrates cyclic peptide structure prediction and sequence-design approaches.2
These advances support structure-guided exploration of macrocycle space. Project methods are selected according to target information, chemical representation, validation needs and applicable software terms.
Project questions
Yes. De novo design begins with the target and binding objective. Feasibility depends on structural support for the chosen site and a suitable experimental route to test the resulting candidates.
We first assess predicted structures and local confidence around potential design regions. Flexible or poorly resolved sites may require a revised construct, a different region or additional experimental information.
Yes. Structural complexes, mutagenesis data, epitope information and competitor-binding results can define constraints. These inputs help connect the intended pose to a meaningful competition or functional assay.
Selected noncanonical residues and modifications can be evaluated where modeling and synthesis support their chemistry. The proposal specifies which chemical features are explored in the initial design and which are introduced during follow-up optimization.
The scope reflects target preparation, design complexity, chemical diversity and the planned experiments. We agree on computational nominations, synthesis batches and review points before work begins; synthesis and validation schedules are planned separately.
Yes. Confirmed binders can enter analog design, stability optimization or conjugation studies. Ownership, confidentiality, data use and the scope of follow-up work are documented in the project agreement.
Your next design campaign starts here
Share the target, available structures, desired biological effect and whether you need computational design, synthesis or experimental validation. We will provide initial project feedback within 24 hours.
For structure files or supporting data, email contact@computabio.com.
For Research Use Only.
Submit your project details below, and our team will respond within 24 hours.
Talk to our technical team about your project!
I Want To Talk